|
1
|
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM
and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qiu M, Hu J, Yang D, Cosgrove DP and Xu R:
Pattern of distant metastases in colorectal cancer: A SEER based
study. Oncotarget. 6:38658–38666. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zarour LR, Anand S, Billingsley KG, Bisson
WH, Cercek A, Clarke MF, Coussens LM, Gast CE, Geltzeiler CB,
Hansen L, et al: Colorectal cancer liver metastasis: Evolving
paradigms and future directions. Cell Mol Gastroenterol Hepatol.
3:163–173. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Welch DR and Hurst DR: Defining the
hallmarks of metastasis. Cancer Res. 79:3011–3027. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lambert AW, Pattabiraman DR and Weinberg
RA: Emerging biological principles of metastasis. Cell.
168:670–691. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hirata A, Hatano Y, Niwa M, Hara A and
Tomita H: Heterogeneity of colon cancer stem cells. Adv Exp Med
Biol. 1139:115–126. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tauriello DV, Calon A, Lonardo E and
Batlle E: Determinants of metastatic competency in colorectal
cancer. Mol Oncol. 11:97–119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Puccini A, Xiu J, Goldberg RM, Grothey A,
Shields AF, Salem ME, Seeber A, Battaglin F, Berger MD, El-Deiry
WS, et al: Molecular differences between lymph nodes (LNs) and
distant metastases (mets) in colorectal cancer (CRC). J Clin Oncol.
37 (Suppl 15):S31302019. View Article : Google Scholar
|
|
10
|
Kamal Y, Schmit SL, Hoehn HJ, Amos CI and
Frost HR: Transcriptomic differences between primary colorectal
adenocarcinomas and distant metastases reveal metastatic colorectal
cancer subtypes. Cancer Res. 79:4227–4241. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pretzsch E, Bösch F, Neumann J, Ganschow
P, Bazhin A, Guba M, Werner J and Angele M: Mechanisms of
metastasis in colorectal cancer and metastatic organotropism:
Hematogenous versus peritoneal spread. J Oncol. 2019:74071902019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tariq K and Ghias K: Colorectal cancer
carcinogenesis: A review of mechanisms. Cancer Biol Med.
13:120–135. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ramaswamy S, Ross KN, Lander ES and Golub
TR: A molecular signature of metastasis in primary solid tumors.
Nat Genet. 33:49–54. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Naxerova K and Jain RK: Using tumour
phylogenetics to identify the roots of metastasis in humans. Nat
Rev Clin Oncol. 12:258–272. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meacham CE and Morrison SJ: Tumour
heterogeneity and cancer cell plasticity. Nature. 501:328–337.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sottoriva A, Kang H, Ma Z, Graham TA,
Salomon MP, Zhao J, Marjoram P, Siegmund K, Press MF, Shibata D and
Curtis C: A big bang model of human colorectal tumor growth. Nat
Genet. 47:209–216. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu Z, Ding J, Ma Z, Sun R, Seoane JA,
Scott Shaffer J, Suarez CJ, Berghoff AS, Cremolini C, Falcone A, et
al: Quantitative evidence for early metastatic seeding in
colorectal cancer. Nat Genet. 51:1113–1122. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Holch JW, Ricard I, Stintzing S, Modest DP
and Heinemann V: The relevance of primary tumour location in
patients with metastatic colorectal cancer: A meta-analysis of
first-line clinical trials. Eur J Cancer. 70:87–98. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Auguste P, Fallavollita L, Wang N, Burnier
J, Bikfalvi A and Brodt P: The host inflammatory response promotes
liver metastasis by increasing tumor cell arrest and extravasation.
Am J Pathol. 170:1781–1792. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Riihimäki M, Hemminki A, Sundquist J and
Hemminki K: Patterns of metastasis in colon and rectal cancer. Sci
Rep. 6:297652016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Prasanna T, Craft PS, Chua YJ, Karapetis
CS, Gibbs P, Wong R, Tie J, Roder DM, Price TJ, Padbury R, et al:
The outcome of patients (pts) with metastatic colorectal cancer
(mCRC) based on site of metastases (mets) and the impact of
molecular markers and site of primary cancer on metastatic pattern.
J Clin Oncol. 35 (Suppl 15):S35602017. View Article : Google Scholar
|
|
22
|
Sadahiro S, Suzuki S, Ishikawa K, Nakamura
T, Tanaka Y, Ishizu K, Yasuda S, Makuuchi H and Murayama C:
Estimation of the time of pulmonary metastasis in colorectal cancer
patients with isolated synchronous liver metastasis. Jpn J Clin
Oncol. 35:18–22. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu J, Wang D, Zhang C, Zhang Z, Chen X,
Lian J, Liu J, Wang G, Yuan W, Sun Z, et al: Identification of
liver metastasis-associated genes in human colon carcinoma by mRNA
profiling. Chin J Cancer Res. 30:633–646. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schweiger T, Liebmann-Reindl S, Glueck O,
Starlinger P, Laengle J, Birner P, Klepetko W, Pils D, Streubel B
and Hoetzenecker K: Mutational profile of colorectal cancer lung
metastases and paired primary tumors by targeted next generation
sequencing: Implications on clinical outcome after surgery. J
Thorac Dis. 10:6147–6157. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hugen N, van de Velde CJH, de Wilt JHW and
Nagtegaal ID: Metastatic pattern in colorectal cancer is strongly
influenced by histological subtype. Ann Oncol. 25:651–657. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Andres SF, Williams KN and Rustgi AK: The
molecular basis of metastatic colorectal cancer. Curr Colorectal
Cancer Rep. 14:69–79. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hanahan D and Weinber RA: The hallmark of
cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hanahan D and Weinber RA: The hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
De Smedt L, Palmans S, Andel D, Govaere O,
Boeckx B, Smeets D, Galle E, Wouters J, Barras D, Suffiotti M, et
al: Expression profiling of budding cells in colorectal cancer
reveals an EMT-like phenotype and molecular subtype switching. Br J
Cancer. 116:58–65. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheung KJ, Gabrielson E, Werb Z and Ewald
AJ: Collective invasion in breast cancer requires a conserved basal
epithelial program. Cell. 155:1639–1651. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Revenu C and Gilmour D: EMT 2.0: Shaping
epithelia through collective migration. Curr Opin Genet Dev.
19:338–342. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Westcott JM, Prechtl AM, Maine EA, Dang
TT, Esparza MA, Sun H, Zhou Y, Xie Y and Pearson GW: An
epigenetically distinct breast cancer cell subpopulation promotes
collective invasion. J Clin Invest. 125:1927–1943. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ye X, Tam WL, Shibue T, Kaygusuz Y,
Reinhardt F, Ng Eaton E and Weinberg RA: Distinct EMT programs
control normal mammary stem cells and tumour-initiating cells.
Nature. 525:256–260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Brabletz T, Hlubek F, Spaderna S,
Schmalhofer O, Hiendlmeyer E, Jung A and Kirchner T: Invasion and
metastasis in colorectal cancer: Epithelial-mesenchymal transition,
mesenchymal-epithelial transition, stem cells and beta-catenin.
Cells Tissues Organs. 179:56–65. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fan F, Samuel S, Evans KW, Lu J, Xia L,
Zhou Y, Sceusi E, Tozzi F, Ye XC, Mani SA and Ellis LM:
Overexpression of snail induces epithelial-mesenchymal transition
and a cancer stem cell-like phenotype in human colorectal cancer
cells. Cancer Med. 1:5–16. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pang R, Law WL, Chu AC, Poon JT, Lam CS,
Chow AK, Ng L, Cheung LW, Lan XR, Lan HY, et al: A subpopulation of
CD26+ cancer stem cells with metastatic capacity in
human colorectal cancer. Cell Stem Cell. 6:603–615. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nakano M, Kikushige Y, Miyawaki K,
Kunisaki Y, Mizuno S, Takenaka K, Tamura S, Okumura Y, Ito M,
Ariyama H, et al: Dedifferentiation process driven by TGF-beta
signaling enhances stem cell properties in human colorectal cancer.
Oncogene. 38:780–793. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Watanabe T, Kobunai T, Yamamoto Y, Matsuda
K, Ishihara S, Nozawa K, Iinuma H, Kanazawa T, Tanaka T, Konishi T,
et al: Gene expression of mesenchyme forkhead 1 (FOXC2)
significantly correlates with the degree of lymph node metastasis
in colorectal cancer. Int J Surg. 96:207–216. 2011. View Article : Google Scholar
|
|
39
|
Sánchez-Tilló E, de Barrios O, Siles L,
Cuatrecasas M, Castells A and Postigo A: β-catenin/TCF4 complex
induces the epithelial-to-mesenchymal transition (EMT)-activator
ZEB1 to regulate tumor invasiveness. Proc Natl Acad Sci USA.
108:19204–19209. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Han X, Fang X, Lou X, Hua D, Ding W, Foltz
G, Hood L, Yuan Y and Lin B: Silencing SOX2 induced
mesenchymal-epithelial transition and its expression predicts liver
and lymph node metastasis of CRC patients. PLoS One. 7:e413352012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dai X, Ge J, Wang X, Qian X, Zhang C and
Li X: OCT4 regulates epithelial-mesenchymal transition and its
knockdown inhibits colorectal cancer cell migration and invasion.
Oncol Rep. 29:155–160. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Meng HM, Zheng P, Wang XY, Liu C, Sui HM,
Wu SJ, Zhou J, Ding YQ and Li J: Over-expression of Nanog predicts
tumor progression and poor prognosis in colorectal cancer. Cancer
Biol Ther. 9:295–302. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lu MH, Huang CC, Pan MR, Chen HH and Hung
WC: Prospero homeobox 1 promotes epithelial-mesenchymal transition
in colon cancer cells by inhibiting E-cadherin via miR-9. Clin
Cancer Res. 18:6416–6425. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ono H, Imoto I, Kozakiet K, Tsuda H,
Matsui T, Kurasawa Y, Muramatsu T, Sugihara K and Inazawa J: SIX1
promotes epithelial-mesenchymal transition in colorectal cancer
through ZEB1 activation. Oncogene. 31:4923–4934. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Takahashi Y, Sawada G, Kurashige J, Uchi
R, Matsumura T, Ueo H, Takano Y, Akiyoshi S, Eguchi H, Sudo T, et
al: Paired related homoeobox 1, a new EMT inducer, is involved in
metastasis and poor prognosis in colorectal cancer. Br J Cancer.
109:307–311. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Belton A, Gabrovsky A, Bae YK, Reeves R,
Iacobuzio-Donahue C, Huso DL and Resar LM: HMGA1 induces intestinal
polyposis in transgenic mice and drives tumor progression and stem
cell properties in colon cancer cells. PLoS One. 7:e300342012.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Diesch J, Sanij E, Gilan O, Love C, Tran
H, Fleming NI, Ellul J, Amalia M, Haviv I, Pearson RB, et al:
Widespread FRA1-dependent control of mesenchymal
transdifferentiation programs in colorectal cancer cells. PLoS One.
9:e889502014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Toiyama Y, Yasuda H, Saigusa S, Tanaka K,
Inoue Y, Goel A and Kusunoki M: Increased expression of Slug and
Vimentin as novel predictive biomarkers for lymph node metastasis
and poor prognosis in colorectal cancer. Carcinogenesis.
34:2548–2557. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Janda E, Lehmann K, Killisch I, Jechlinger
M, Herzig M, Downward J, Beug H and Grünert S: Ras and TGF[beta]
cooperatively regulate epithelial cell plasticity and metastasis:
Dissection of Ras signaling pathways. J Cell Biol. 156:299–313.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gotzmann J, Mikula M, Eger A,
Schulte-Hermann R, Foisner R, Beug H and Mikulitz W: Molecular
aspects of epithelial cell plasticity: Implications for local tumor
invasion and metastasis. Mutat Res. 566:9–20. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Maffeis V, Nicolè L and Cappellesso R:
RAS, cellular plasticity, and tumor budding in colorectal cancer.
Front Oncol. 9:12552019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wan Z, Chai R, Yuan H, Chen B, Dong Q,
Zheng B, Mou X, Pan W, Tu Y, Yang Q, et al: MEIS2 promotes cell
migration and invasion in colorectal cancer. Oncol Rep. 42:213–223.
2019.PubMed/NCBI
|
|
53
|
Sugai T, Yamada N, Eizuka M, Sugimoto R,
Uesugi N, Osakabe M, Ishida K, Otsuka K, Sasaki A and Matsumoto T:
Vascular invasion and stromal S100A4 expression at the invasive
front of colorectal cancer are novel determinants and tumor
prognostic markers. J Cancer. 8:1552–1561. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Varga J and Greten FR: Cell plasticity in
epithelial homeostasis and tumorigenesis. Nat Cell Biol.
19:1133–1141. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ishay-Ronen D, Diepenbruck M, Kalathur
RKR, Sugiyama N, Tiede S, Ivanek R, Bantug G, Morini MF, Wang J,
Hess C and Christofori G: Gain fat-lose metastasis: Converting
invasive breast cancer cells into adipocytes inhibits cancer
metastasis. Cancer Cell. 35:17–32.e6. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Celià-Terrassa T and Kang Y: Distinctive
properties of metastasis-initiating cells. Genes Dev. 30:892–908.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Tam WL and Weinberg RA: The epigenetics of
epithelial-mesenchymal plasticity in cancer. Nat Med. 19:1438–1449.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Mohd-Sarip A, Teeuwssen M, Bot AG, De
Herdt MJ, Willems SM, Baatenburg de Jong RJ, Looijenga LHJ,
Zatreanu D, Bezstarosti K, van Riet J, et al: DOC1-dependent
recruitment of NURD reveals antagonism with SWI/SNF during
epithelial-mesenchymal transition in oral cancer cells. Cell Rep.
20:61–75. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Pastushenko I and Blanpain C: EMT
transition states during tumor progression and metastasis. Trends
Cell Biol. 29:212–226. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Liu S, Cong Y, Wang D, Sun Y, Deng L, Liu
Y, Martin-Trevino R, Shang L, McDermott SP, Landis MD, et al:
Breast cancer stem cells transition between epithelial and
mesenchymal states reflective of their normal counterparts. Stem
Cell Report. 2:78–91. 2013. View Article : Google Scholar
|
|
62
|
Biddle A, Gammon L, Liang X, Costea DE and
Mackenzie IC: Phenotypic plasticity determines cancer stem cell
therapeutic resistance in oral squamous cell carcinoma.
EBioMedicine. 4:138–145. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Katsuno Y, Meyer DS, Zhang Z, Shokat KM,
Akhurst RJ, Miyazono K and Derynck R: Chronic TGF-β exposure drives
stabilized EMT, tumor stemness, and cancer drug resistance with
vulnerability to bitopic mTOR inhibition. Sci Signal.
12:eaau85442019. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Obenauf AC and Massagué J: Surviving at a
distance: Organ specific metastasis. Trends Cancer. 1:76–91. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Agnoletto C, Corrà F, Minotti L,
Baldassari F, Crudele F, Cook WJJ, Di Leva G, d'Adamo AP, Gasparini
P and Volinia S: Heterogeneity in circulating tumor cells: The
relevance of the stem-cell subset. Cancers (Basel). 11:4832019.
View Article : Google Scholar
|
|
66
|
Guinney J, Dienstmann R, Wang X, de
Reyniès A, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda
G, Angelino P, et al: The consensus molecular subtypes of
colorectal cancer. Nat Med. 21:1350–1356. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Kauffmann A, Rosselli F, Lazar V,
Winnepenninckx V, Mansuet-Lupo A, Dessen P, van den Oord JJ, Spatz
A and Sarasin A: High expression of DNA repair pathways is
associated with metastasis in melanoma patients. Oncogene.
27:565–573. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Trinh A, Lädrach C, Dawson HE, Ten Hoorn
S, Kuppen PJ, Reimers MS, Koopman M, Punt CJ, Lugli A, Vermeulen L
and Zlobec I: Tumour budding is associated with the mesenchymal
colon cancer subtype and RAS/RAF mutations: A study of 1320
colorectal cancers with consensus molecular subgroup. Br J Cancer.
119:1244–1251. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Sveen A, Cremolini C and Dienstmann R:
Predictive modeling in colorectal cancer: Time to move beyond
consensus molecular subtypes. Ann Oncol. 30:1682–1685. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zhou Y, Xia L, Wang H, Oyang L, Su M, Liu
Q, Lin J, Tan S, Tian Y, Liao Q and Cao D: Cancer stem cells in
progression of colorectal cancer. Oncotarget. 9:33403–33415. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Carmon KS, Gong X, Yi J, Wu L, Thomas A,
Moore CM, Masuho I, Timson DJ, Martemyanov KA and Liu QJ: LGR5
receptor promotes cell-cell adhesion in stem cells and colon cancer
cells via the IQGAP1-Rac1 pathway. J Biol Chem. 292:14989–15001.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Lam CS, Cheung AH, Wong SK, Wan TM, Ng L,
Chow AK, Cheng NS, Pak RC, Li HS, Man JH, et al: Prognostic
significance of CD26 in patients with colorectal cancer. PLoS One.
9:e985822014. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Mortier A, Gouwy M, Van Damme J, Proost P
and Struyf S: CD26/dipeptidylpeptidase IV-chemokine interactions:
Double-edged regulation of inflammation and tumor biology. J Leukoc
Biol. 99:955–969. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Ma L, Dong L and Chang P: CD44v6 engages
in colorectal cancer progression. Cell Death Dis. 10:302019.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Liu H, Ong SE, Badu-Nkansah K, Schindler
J, White FM and Hynes RO: CUB-domain-containing protein 1 (CDCP1)
activates Src to promote melanoma metastasis. Proc Natl Acad Sci
USA. 108:1379–1384. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Mohamed SY, Kaf RM, Ahmed MM, Elwan A,
Ashour HR and Ibrahim A: The prognostic value of cancer stem cell
markers (Notch1, ALDH1, and CD44) in primary colorectal carcinoma.
J Gastrointest Cancer. 50:824–837. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Jackstadt R, van Hooff SR, Leach JD,
Cortes-Lavaud X, Lohuis JO, Ridgway RA, Wouters VM, Roper J,
Kendall TJ, Roxburgh CS, et al: Epithelial NOTCH signaling rewires
the tumor microenvironment of colorectal cancer to drive
poor-prognosis subtypes and metastasis. Cancer Cell. 36:319–336.e7.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Van der Waals LM, Borel Rinkes IH and
Kranenburg O: ALDH1A1 expression is associated with poor
differentiation, ‘right-sidedness’ and poor survival in human
colorectal cancer. PLoS One. 13:e02055362018. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Vázquez-Iglesias L, Barcia-Castro L,
Rodríguez-Quiroga M, Páez de la Cadena M, Rodríguez-Berrocal J and
Cordero OJ: Surface expression marker profile in colon cancer cell
lines and sphere-derived cells suggests complexity in
CD26+ cancer stem cells subsets. Biol Open.
8:bio0416732019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Dotse E and Bian Y: Isolation of
colorectal cancer stem-like cells. Cytotechnology. 68:609–619.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
De Sousa E, Melo F, Wang X, Jansen M,
Fessler E, Trinh A, de Rooij LP, de Jong JH, de Boer OJ, van
Leersum R, Bijlsma MF, et al: Poor-prognosis colon cancer is
defined by a molecularly distinct subtype and develops from
serrated precursor lesions. Nat Med. 19:614–618. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Testa U, Pelosi E and Castelli G:
Colorectal cancer: Genetic abnormalities, tumor progression, tumor
heterogeneity, clonal evolution and tumor-initiating cells. Med Sci
(Basel). 6:312018.
|
|
83
|
Fedyanin M, Popova A, Polyanskaya E and
Tjulandin S: Role of stem cells in colorectal cancer progression
and prognostic and predictive characteristics of stem cell markers
in colorectal cancer. Curr Stem Cell Res Ther. 12:19–30. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Lieto E, Galizia G, Orditura M, Romano C,
Zamboli A, Castellano P, Mabilia A, Auricchio A, De Vita F and
Gemei M: CD26-positive/CD326-negative circulating cancer cells as
prognostic markers for colorectal cancer recurrence. Oncol Lett.
9:542–550. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Todaro M, Gaggianesi M, Catalano V,
Benfante A, Iovino F, Biffoni M, Apuzzo T, Sperduti I, Volpe S,
Cocorullo G, et al: CD44v6 is a marker of constitutive and
reprogrammed cancer stem cells driving colon cancer metastasis.
Cell Stem Cell. 14:342–356. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Zhang SS, Han ZP, Jing YY, Tao SF, Li TJ,
Wang H, Wang Y, Li R, Yang Y, Zhao X, et al: CD133(+)CXCR4(+) colon
cancer cells exhibit metastatic potential and predict poor
prognosis of patients. BMC Med. 10:852012. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Gao W, Chen L, Ma Z, Du Z, Zhao Z, Hu Z
and Li Q: Isolation and phenotypic characterization of colorectal
cancer stem cells with organ-specific metastatic potential.
Gastroenterology. 145:636–646.e5. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Tong K, Pellón-Cárdenas O, Sirihorachai
VR, Warder BN, Kothari OA, Perekatt AO, Fokas EE, Fullem RL, Zhou
A, Thackray JK, et al: Degree of tissue differentiation dictates
susceptibility to BRAF-driven colorectal cancer. Cell Rep.
21:3833–3845. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Durinikova E, Kozovska Z, Poturnajova M,
Plava J, Cierna Z, Babelova A, Bohovic R, Schmidtova S, Tomas M,
Kucerova L and Matuskova M: ALDH1A3 upregulation and spontaneous
metastasis formation is associated with acquired chemoresistance in
colorectal cancer cells. BMC Cancer. 18:8482018. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Boland CR and Goel A: Microsatellite
instability in colorectal cancer. Gastroenterology.
138:2073–2087.e3. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Mármol I, Sánchez-de-Diego C, Pradilla
Dieste A, Cerrada E and Rodriguez Yoldi MJ: Colorectal carcinoma: A
general overview and future perspectives in colorectal cancer. Int
J Mol Sci. 18:1972017. View Article : Google Scholar
|
|
92
|
Jung J, Kang Y, Lee YJ, Kim E, Ahn B, Lee
E, Kim JY, Lee JH, Lee Y, Kim CH and Chae YS: Comparison of the
mismatch repair system between primary and metastatic colorectal
cancers using immunohistochemistry. J Pathol Transl Med.
51:129–136. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Chen W, Swanson BJ and Frankel WL:
Molecular genetics of microsatellite-unstable colorectal cancer for
pathologists. Diagn Pathol. 12:242017. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Pino MS and Chung DC: The chromosomal
instability pathway in colon cancer. Gastroenterology.
138:2059–2072. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Thanki K, Nicholls ME, Gajjar A, Senagore
AJ, Qiu S, Szabo C, Hellmich MR and Chao C: Consensus molecular
subtypes of colorectal cancer and their clinical implications. Int
Biol Biomed J. 3:105–111. 2017.PubMed/NCBI
|
|
96
|
Fumagalli A, Drost J, Suijkerbuijk SJ, van
Boxtel R, de Ligt J, Offerhaus GJ, Begthel H, Beerling E, Tan EH,
Sansom OJ, et al: Genetic dissection of colorectal cancer
progression by orthotopic transplantation of engineered cancer
organoids. Proc Natl Acad Sci USA. 114:E2357–E2364. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Zhao M, Mishra L and Deng CX: The role of
TGF-β/SMAD4 signaling in cancer. Int J Biol Sci. 14:111–123. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Boutin AT, Liao WT, Wang M, Hwang SS,
Karpinets TV, Cheung H, Chu GC, Jiang S, Hu J, Chang K, et al:
Oncogenic KRAS drives invasion and maintains metastases in
colorectal cancer. Genes Dev. 31:370–382. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Wenzel J, Rose K, Haghighi EB, Lamprecht
C, Rauen G, Freihen V, Kesselring R, Boerries M and Hecht A: Loss
of the nuclear Wnt pathway effector TCF7L2 promotes migration and
invasion of human colorectal cancer cells. Oncogene. 39:3893–3909.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Major MB, Camp ND, Berndt JD, Yi X,
Goldenberg SJ, Hubbert C, Biechele TL, Gingras AC, Zheng N, Maccoss
MJ, et al: Wilms tumor suppressor WTX negatively regulates
WNT/beta-catenin signaling. Science. 316:1043–1046. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Steffen DJ, Amornphimoltham P, Valera JLC,
Taylor S, Hunter T, Tamayo P and Gutkind JS: GNAS-PKA Oncosignaling
Network in Colorectal Cancer. Pharmacology. 31:lb5272017.
|
|
102
|
Lieu C and Kopetz S: The SRC family of
protein tyrosine kinases: A new and promising target for colorectal
cancer therapy. Clin Colorectal Cancer. 9:89–94. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Jin X, Zhai B, Fang T, Guo X and Xu L:
FXR1 is elevated in colorectal cancer and acts as an oncogene.
Tumor Biol. 37:2683–2690. 2016. View Article : Google Scholar
|
|
104
|
Gumireddy K, Li A, Yan J, Setoyama T,
Johannes GJ, Ørom UA, Tchou J, Liu Q, Zhang L, Speicher DW, et al:
Identification of a long non-coding RNA-associated RNP complex
regulating metastasis at the translational step. EMBO J.
32:2672–2684. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Xia P, Choi AH, Deng Z, Yang Y, Zhao J,
Wang Y, Hardwidge PR and Zhu G: Cell membrane-anchored MUC4
promotes tumorigenicity in epithelial carcinomas. Oncotarget.
8:14147–14157. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
De Robertis M, Arigoni M, Loiacono L,
Riccardo F, Calogero RA, Feodorova Y, Tashkova D, Belovejdov V,
Sarafian V, Cavallo F and Signori E: Novel insights into Notum and
glypicans regulation in colorectal cancer. Oncotarget.
6:41237–41257. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Lui VW, Peyser ND, Ng PK, Hritz J, Zeng Y,
Lu Y, Li H, Wang L, Gilbert BR, General IJ, et al: Frequent
mutation of receptor protein tyrosine phosphatases provides a
mechanism for STAT3 hyperactivation in head and neck cancer. Proc
Natl Acad Sci USA. 111:1114–1119. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Brabletz T, Jung A, Reu S, Porzner M,
Hlubek F, Kunz-Schughart LA, Knuechel R and Kirchner T: Variable
beta-catenin expression in colorectal cancers indicates tumor
progression driven by the tumor environment. Proc Natl Acad Sci
USA. 98:10356–10361. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Fodde R, Smits R and Clevers H: APC,
signal transduction and genetic instability in colorectal cancer.
Nat Rev Cancer. 1:55–67. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Gregorieff A and Clevers H: Wnt signaling
in the intestinal epithelium: From endoderm to cancer. Genes Dev.
19:877–890. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Brabletz T, Jung A, Hermann K, Günther K,
Hohenberger W and Kirchner T: Nuclear overexpression of the
oncoprotein beta-catenin in colorectal cancer is localized
predominantly at the invasion front. Pathol Res Pract. 194:701–704.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Le NH, Franken P and Fodde R:
Tumour-stroma interactions in colorectal cancer: Converging on
beta-catenin activation and cancer stemness. Br J Cancer.
98:1886–1893. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Teeuwssen M and Fodde R: Cell
heterogeneity and phenotypic plasticity in metastasis formation:
The case of colon cancer. Cancers (Basel). 11:13682019. View Article : Google Scholar
|
|
114
|
Brocardo M and Henderson B: APC shuttling
to the membrane, nucleus and beyond. Trends Cell Boil. 18:587–596.
2008. View Article : Google Scholar
|
|
115
|
Sarli L, Bottarelli L, Bader G, Iusco D,
Pizzi S, Costi R, D'Adda T, Bertolani M, Roncoroni L and Bordi C:
Association between recurrence of sporadic colorectal cancer, high
level of microsatellite instability, and loss of heterozygosity at
chromosome 18q. Dis Colon Rectum. 47:1467–1482. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Munro AJ, Lain S and Lane DP: P53
abnormalities and outcomes in colorectal cancer: A systematic
review. Br J Cancer. 92:434–444. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Prior IA, Lewis PD and Mattos C: A
comprehensive survey of Ras mutations in cancer. Cancer Res.
72:2457–2467. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Makrodouli E, Oikonomou E, Koc M, Andera
L, Sasazuki T, Shirasawa S and Pintzas A: BRAF and RAS oncogenes
regulate Rho GTPase pathways to mediate migration and invasion
properties in human colon cancer cells: A comparative study. Mol
Cancer. 10:1182011. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Lemieux E, Bergeron S, Durand V, Asselin
C, Saucier C and Rivard N: Constitutively active MEK1 is sufficient
to induce epithelial-to-mesenchymal transition in intestinal
epithelial cells and to promote tumor invasionand metastasis. Int J
Cancer. 125:1575–1586. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Yamazaki D, Kurisu S and Takenawa T:
Involvement of Rac and Rho signaling in cancer cell motility in 3D
substrates. Oncogene. 28:1570–1583. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Sanz-Moreno V and Marshall CJ: The
plasticity of cytoskeletal dynamics underlying neoplastic cell
migration. Curr Opin Cell Biol. 22:690–696. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Koveitypour Z, Panahi F, Vakilian M,
Peymani M, Seyed Forootan F, Nasr Esfahani MH and Ghaedi K:
Signaling pathways involved in colorectal cancer progression. Cell
Biosci. 9:972019. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Atreya CE, Sangale Z, Xu N, Matli MR,
Tikishvili E, Welbourn W, Stone S, Shokat KM and Warren RS: PTEN
expression is consistent in colorectal cancer primaries and
metastases and associates with patient survival. Cancer Med.
2:496–506. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Day F, Muranyi A, Singh S, Shanmugam K,
Williams D, Byrne D, Pham K, Palmieri M, Tie J, Grogan T, et al: A
mutant BRAF V600E-specific immunohistochemical assay: Correlation
with molecular mutation status and clinical outcome in colorectal
cancer. Target Oncol. 10:99–109. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Yaeger R, Cercek A, O'Reilly EM, Reidy DL,
Kemeny N, Wolinsky T, Capanu M, Gollub MJ, Rosen N, Berger MF, et
al: Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant
metastatic colorectal cancer patients. Clin Cancer Res.
21:1313–1320. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Wong CK, Lambert AW, Ozturk S, Papageorgis
P, Lopez D, Shen N, Sen Z, Abdolmaleky HM, Győrffy B, Feng H and
Thiagalingam S: Targeting RICTOR sensitizes SMAD4-negative colon
cancer to irinotecan. Mol Cancer Res. 18:414–423. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Zou Z, Tao T, Li H and Zhu X: mTOR
signaling pathway and mTOR inhibitors in cancer: Progress and
challenges. Cell Biosci. 10:312020. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Demkova L and Kucerova L: Role of the
HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma. Mol
Cancer. 17:262018. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Cui YM, Jiao HL, Ye YP, Chen CM, Wang JX,
Tang N, Li TT, Lin J, Qi L, Wu P, et al: FOXC2 promotes colorectal
cancer metastasis by directly targeting MET. Oncogene.
34:4379–4390. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Stein U, Walther W, Arlt F, Schwabe H,
Smith J, Fichtner I, Birchmeier W and Schlag PM: MACC1, a newly
identified key regulator of HGF-MET signaling, predicts colon
cancer metastasis. Nat Med. 15:59–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Pichorner A, Sack U, Kobelt D, Kelch I,
Arlt F, Smith J, Walther W, Schlag PM and Stein U: In vivo imaging
of colorectal cancer growth and metastasis by targeting MACC1 with
shRNA in xenografted mice. Clin Exp Metastasis. 29:573–583. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Juneja M, Kobelt D, Walther W, Voss C,
Smith J, Specker E, Neuenschwander M, Gohlke B, Dahlmann M,
Radetzki S, et al: Statin and rottlerin small-molecule inhibitors
restrict colon cancer progression and metastasis via MACC1. PLoS
Biol. 15:e20007842017. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Glebov OK, Rodriguez LM, Nakahara K,
Jenkins J, Cliatt J, Humbyrd CJ, DeNobile J, Soballe P, Simon R,
Wright G, et al: Distinguishing right from left colon by the
pattern of gene expression. Cancer Epidemiol Biomark Prev.
12:755–762. 2003.
|
|
134
|
Baran B, Mert Ozupek N, Yerli Tetik N,
Acar E, Bekcioglu O and Baskin Y: Difference between left-sided and
right-sided colorectal cancer: A focused review of literature.
Gastroenterol Res. 11:264–273. 2018. View Article : Google Scholar
|
|
135
|
Lee MS, Menter DG and Kopetz S: Right
versus left colon cancer biology: Integrating the consensus
molecular subtypes. J Natl Compr Canc Netw. 15:411–419. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Weinberg BA: Anti-EGFR therapy in
right-sided metastatic colorectal cancer: Right or wrong? J Natl
Compr Canc Netw. 16:1547–1548. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Loree JM, Pereira AAL, Lam M, Willauer AN,
Raghav K, Dasari A, Morris VK, Advani S, Menter DG, Eng C, et al:
Classifying colorectal cancer by tumor location rather than
sidedness highlights a continuum in mutation profiles and consensus
molecular subtypes. Clin Cancer Res. 24:1062–1072. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Hugen N, Brown G, Glynne-Jones R, de Wilt
JH and Nagtegaal ID: Advances in the care of patients with mucinous
colorectal cancer. Nat Rev Clin Oncol. 13:361–369. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Esterházy D, Canesso MC, Mesin L, Muller
PA, de Castro TB, Lockhart A, ElJalby M, Faria AM and Mucida D:
Compartmentalized gut lymph node drainage dictates adaptive immune
responses. Nature. 569:126–130. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Piskounova E, Agathocleous M, Murphy MM,
Hu Z, Huddlestun SE, Zhao Z, Leitch AM, Johnson TM, DeBerardinis RJ
and Morrison SJ: Oxidative stress inhibits distant metastasis by
human melanoma cells. Nature. 527:186–191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Llosa NJ, Cruise M, Tam A, Wicks EC,
Hechenbleikner EM, Taube JM, Blosser RL, Fan H, Wang H, Luber BS,
et al: The vigorous immune microenvironment of microsatellite
instable colon cancer is balanced by multiple counter-inhibitory
checkpoints. Cancer Discov. 5:43–51. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Deschoolmeester V, Baay M, Van Marck E,
Weyler J, Vermeulen P, Lardon F and Vermorken JB: Tumor
infiltrating lymphocytes: An intriguing player in the survival of
colorectal cancer patients. BMC Immunol. 11:192010. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Salama P, Phillips M, Grieu F, Morris M,
Zeps N, Joseph D, Platell C and Iacopetta B: Tumor-infiltrating
FOXP3+ T regulatory cells show strong prognostic
significance in colorectal cancer. J Clin Oncol. 27:186–192. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Schwitalle Y, Kloor M, Eiermann S,
Linnebacher M, Kienle P, Knaebel HP, Tariverdian M, Benner A and
von Knebel Doeberitz M: Immune response against frameshift-induced
neopeptides in HNPCC patients and healthy HNPCC mutation carriers.
Gastroenterology. 134:988–997. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Han Y, Liu D and Li L: PD-1/PD-L1 pathway:
Current researches in cancer. Am J Cancer Res. 10:727–742.
2020.PubMed/NCBI
|
|
146
|
Kreidieh M, Mukherji D, Temraz S and
Shamseddine A: Expanding the scope of immunotherapy in colorectal
cancer: Current clinical approaches and future directions. Biomed
Res Int. 2020:90372172020. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Kroemer G, Galluzzi L, Zitvogel L and
Fridman WH: Colorectal cancer: The first neoplasia found to be
under immunosurveillance and the last one to respond to
immunotherapy? Oncoimmunology. 4:e10585972015. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Le DT, Uram JN, Wang H, Bartlett BR,
Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, et
al: PD-1 blockade in tumors with mismatch-repair DEfiCiency. N Engl
J Med. 372:2509–2520. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Mlecnik B, Bindea G, Kirilovsky A, Angell
HK, Obenauf AC, Tosolini M, Church SE, Maby P, Vasaturo A, Angelova
M, et al: The tumor microenvironment and Immunoscore are critical
determinants of dissemination to distant metastasis. Sci Trans Med.
8:327ra262016. View Article : Google Scholar
|
|
150
|
Mlecnik B, Van den Eynde M, Bindea G,
Church SE, Vasaturo A, Fredriksen T, Lafontaine L, Haicheur N,
Marliot F, Debetancourt D, et al: Comprehensive intrametastatic
immune quantification and major impact of immunoscore on survival.
J Natl Cancer Inst. 110:97–108. 2018. View Article : Google Scholar
|
|
151
|
Girardin A, McCall J, Black MA, Edwards F,
Phillips V, Taylor ES, Reeve AE and Kemp RA: Inflammatory and
regulatory T cells contribute to a unique immune microenvironment
in tumor tissue of colorectal cancer patients. Int J Cancer.
132:1842–1850. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Pedrosa L, Esposito F, Thomson TM and
Mauriel J: The tumor microenvironment in colorectal cancer therapy.
Cancers (Basel). 11:11722019. View Article : Google Scholar
|
|
153
|
Kalluri R and Zeisberg M: Fibroblasts in
cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Malanchi I, Santamaria-Martínez A, Susanto
E, Peng H, Lehr HA, Delaloye JF and Huelsken J: Interactions
between cancer stem cells and their niche govern metastatic
colonization. Nature. 481:85–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Calon A, Espinet E, Palomo-Ponce S,
Tauriello DV, Iglesias M, Céspedes MV, Sevillano M, Nadal C, Jung
P, Zhang XH, et al: Dependency of colorectal cancer on a
TGF-β-driven program in stromal cells for metastasis initiation.
Cancer Cell. 22:571–584. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Brown RE, Short SP and Williams CS:
Colorectal cancer and metabolism. Curr Colorectal Cancer Rep.
14:226–241. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Gureev AP, Shaforostova EA and Popov VN:
Regulation of mitochondrial biogenesis as a way for active
longevity: Interaction between the Nrf2 and PGC-1α signaling
pathways. Front Genet. 10:4352019. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Chang CH, Qiu J, O'Sullivan D, Buck MD,
Noguchi T, Curtis JD, Chen Q, Gindin M, Gubin MM, van der Windt GJ,
et al: Metabolic competition in the tumor microenvironment is a
driver of cancer progression. Cell. 162:1229–1241. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Vyas M, Patel N, Nagarajan A, Wajapeyee N,
Jain D and Zhan X: Hypoxia induced HIF-1α expression promotes
angiogenesis, tumor budding cell survival and cell proliferation
arrest in high-grade tumor budding colorectal carcinomas. Int J
Clin Exp Patho. 9:13047–13055. 2016.
|
|
160
|
Ancey PB, Contat C and Meylan E: Glucose
transporters in cancer-from tumor cells to the tumor
microenvironment. FEBS J. 285:2926–2943. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Ritterson Lew C, Guin S and Theodorescu D:
Targeting glycogen metabolism in bladder cancer. Nat Rev Urol.
12:383–391. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Kuo CC, Ling HH, Chiang MC, Chung CH, Lee
WY, Chu CY, Wu YC, Chen CH, Lai YW, Tsai IL, et al: Metastatic
colorectal cancer rewrites metabolic program through a
Glut3-YAP-dependent signaling circuit. Theranostics. 9:2526–2540.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
DeBerardinis RJ: Is cancer a disease of
abnormal cellular metabolism? New angles on an old idea. Genet Med.
10:767–777. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Weber GF: Metabolism in cancer metastasis.
Int Jour Cancer. 138:2061–2066. 2016. View Article : Google Scholar
|
|
165
|
Corté H, Manceau G, Blons H and
Laurent-Puig P: MicroRNA and colorectal cancer. Dig liver dis.
44:195–200. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Bu P, Chen KY, Xiang K, Johnson C, Crown
SB, Rakhilin N, Ai Y, Wang L, Xi R, Astapova I, et al: Aldolase
B-mediated fructose metabolism drives metabolic reprogramming of
colon cancer liver metastasis. Cell Metab. 27:1249–1262.e4. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Wu Z, Wei D, Gao W, Xu Y, Hu Z, Ma Z, Gao
C, Zhu X and Li Q: TPO-induced metabolic reprogramming drives liver
metastasis of colorectal cancer CD110+ tumor-initiating
cells. Cell Stem Cells. 17:47–59. 2015. View Article : Google Scholar
|
|
168
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Cellura D, Pickard K, Quaratino S, Parker
H, Strefford JC, Thomas GJ, Mitter R, Mirnezami AH and Peake NJ:
miR-19-mediated inhibition of transglutaminase-2 leads to enhanced
invasion and metastasis in colorectal cancer. Mol Cancer Res.
13:1095–1105. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Lam CS, Ng L, Chow AK, Wan TM, Yau S,
Cheng NS, Wong SK, Man JH, Lo OS, Foo DC, et al: Identification of
microRNA 885–5p as a novel regulator of tumor metastasis by
targeting CPEB2 in colorectal cancer. Oncotarget. 8:26858–26870.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Shibuya H, Iinuma H, Shimada R, Horiuchi A
and Watanabe T: Clinicopathological and prognostic value of
microRNA-21 and microRNA-155 in colorectal cancer. Oncology.
79:313–320. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Loo JM, Scherl A, Nguyen A, Man FY,
Weinberg E, Zeng Z, Saltz L, Paty PB and Tavazoie SF: Extracellular
metabolic energetics can promote cancer progression. Cell.
160:393–406. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Chi Y and Zhou D: MicroRNAs in colorectal
carcinoma-from pathogenesis to therapy. J Exp Clin Cancer Res.
35:432016. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Heublein S, Albertsmeier M, Pfeifer D,
Loehrs L, Bazhin AV, Kirchner T, Werner J, Neumann J and Angele MK:
Association of differential miRNA expression with hepatic vs.
peritoneal metastatic spread in colorectal cancer. BMC Cancer.
18:2012018. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Siemens H, Neumann J, Jackstadt R,
Mansmann U, Horst D, Kirchner T and Hermeking H: Detection of
miR-34a promoter methylation in combination with elevated
expression of c-Met and β-catenin predicts distant metastasis of
colon cancer. Clin Cancer Res. 19:710–720. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Ma YS, Lv ZW, Yu F, Chang ZY, Cong XL,
Zhong XM, Lu GX, Zhu J and Fu D: MicroRNA-302a/d inhibits the
self-renewal capability and cell cycle entry of liver cancer stem
cells by targeting the E2F7/AKT axis. J Exp Clin Cancer Res.
37:2522018. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Shi L, Jackstadt R, Siemens H, Li H,
Kirchner T and Hermeking H: p53-induced miR-15a/16-1 and AP4 form a
double-negative feedback loop to regulate epithelial-mesenchymal
transition and metastasis in colorectal cancer. Cancer Res.
74:532–542. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Yan TT, Ren LL, Shen CQ, Wang ZH, Yu YN,
Liang Q, Tang JY, Chen YX, Sun DF, Zgodzinski W, et al: miR-508
defines the stem-like/mesenchymal subtype in colorectal cancer.
Cancer Res. 78:1751–1765. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Hur K, Toiyama Y, Takahashi M, Balaguer F,
Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR and Goel A:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Sun Z, Zhang Z, Liu Z, Qiu B, Liu K and
Dong G: MicroRNA-335 inhibits invasion and metastasis of colorectal
cancer by targeting ZEB2. Med Oncol. 31:9822014. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Geng L, Chaudhuri A, Talmon G, Wisecarver
JL, Are C, Brattain M and Wang J: MicroRNA-192 suppresses liver
metastasis of colon cancer. Oncogene. 33:5332–5340. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Hahn S, Jackstadt R, Siemens H, Hünten S
and Hermeking H: SNAIL and miR-34a feed-forward regulation of
ZNF281/ZBP99 promotes epithelial-mesenchymal transition. EMBO J.
32:3079–3095. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Miranda E, Destro A, Malesci A, Balladore
E, Bianchi P, Baryshnikova E, Franchi G, Morenghi E, Laghi L,
Gennari L and Roncalli M: Genetic and epigenetic changes in primary
metastatic and nonmetastatic colorectal cancer. Br J Cancer.
95:1101–1107. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Li Z, Chen Y, Ren WU, Hu S, Tan Z, Wang Y,
Chen Y, Zhang J, Wu J, Li T, et al: Transcriptome alterations in
liver metastases of colorectal cancer after acquired resistance to
cetuximab. Cancer Genom Proteom. 16:207–219. 2019. View Article : Google Scholar
|
|
186
|
Markowitz SD and Bertagnolli MM: Molecular
origins of cancer: Molecular basis of colorectal cancer. N Engl J
Med. 361:2449–2460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Garinis GA, Menounos PG, Spanakis NE,
Papadopoulos K, Karavitis G, Parassi I, Christeli E, Patrinos GP,
Manolis EN and Peros G: Hypermethylation-associated transcriptional
silencing of E-cadherin in primary sporadic colorectal carcinomas.
J Pathol. 198:442–449. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Ryall JG, Cliff T, Dalton S and Sartorelli
V: Metabolic reprogramming of stem cell epigenetics. Cell Stem
Cell. 17:651–662. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Kim JA and Yeom YI: Metabolic signaling to
epigenetic alterations in cancer. Biomol Ther (Seoul). 26:69–80.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Zee BM, Levin RS, Xu B, LeRoy G, Wingreen
NS and Garcia BA: In vivo residue-specific histone methylation
dynamics. J Biol Chem. 285:3341–3350. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Tse JWT, Jenkins LJ, Chionh F and
Mariadason JM: Aberrant DNA methylation in colorectal cancer: What
should we target? Trends Cancer. 3:698–712. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Zentner GE and Henikoff S: Regulation of
nucleosome dynamics by histone modifications. Nat Struct Mol Biol.
20:259–266. 2013. View Article : Google Scholar : PubMed/NCBI
|
